ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 059,53
-0,53%
Dow Jones
43 239,50
0,00%
DAX
22 404,94
-0,53%
Brent Oil
72,695
-0,97%
Bitcoin
80 720,95
-4,69%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ

  6. Kymera Therapeutics Inc (KYMR) Cours

Kymera Therapeutics Inc

Kymera Therapeutics Inc (KYMR)

NASDAQ
30,25
-5,11
(-14,45%)
Fermé 28 Février 10:00PM
Retardé de 15 minutes
28,30
-1,95
( -6,45% )
Avant marché: 1:21PM
Retardé de 15 minutes

Votre Hub pour des idées et discussions en direct en temps réel

Premium

Statistiques et détails clés

Dernier
28,30
Prix Achat
28,50
Prix Vente
41,25
Volume échangé
631
0,00 Fourchette du Jour 0,00
28,30 Plage de 52 semaines 53,27
Cap du marché
1,833B
Clôture Veille
30,25
Ouverture
-
Dernière Transaction
6
@
30.25
Dernière heure de transaction
13:18:55
Volume financier
-
VWAP
-
Volume moyen (3 m)
512 581
Actions en circulation
64 765 274
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-13,33
Bénéfice par action (BPA)
-2,27
Chiffre d'affairess
78,59M
Bénéfice net
-146,96M

À propos de Kymera Therapeutics Inc

Kymera Therapeutics Inc is a biotechnology company pioneering a transformative new approach to treating previously untreatable diseases. The company is advancing the field of targeted protein degradation, accessing the body's innate protein recycling machinery to degrade dysregulated, disease-causin... Kymera Therapeutics Inc is a biotechnology company pioneering a transformative new approach to treating previously untreatable diseases. The company is advancing the field of targeted protein degradation, accessing the body's innate protein recycling machinery to degrade dysregulated, disease-causing proteins. Kymera's Pegasus targeted protein degradation platform harnesses the body's natural protein recycling machinery to degrade disease-causing proteins, with a focus on un-drugged nodes in validated pathways currently inaccessible with conventional therapeutics. It is accelerating drug discovery with an unmatched ability to target and degrade intractable proteins and advance new treatment options for patients. Show more

Secteur
Biological Pds,ex Diagnstics
Industrie
Biological Pds,ex Diagnstics
Site Web
www.kymeratx.com
Siège social
Wilmington, Delaware, USA
Fondé
-
Kymera Therapeutics Inc est coté dans le secteur Biological Pds,ex Diagnstics de la NASDAQ avec le ticker KYMR. Le dernier cours de clôture d'Kymera Therapeutics était de US$30,25. Au cours de la dernière année, les actions de Kymera Therapeutics ont été négociées dans une fourchette de prix de US$ 28,30 à US$ 53,27.

Kymera Therapeutics compte actuellement 64 765 274 actions en circulation. La capitalisation boursière d'Kymera Therapeutics est de US$1,96 milliard. Kymera Therapeutics a un ratio cours/bénéfice (ratio PE) de -13.33.

KYMR Dernières nouvelles

Plus de nouvelles

Form S-8 - Securities to be offered to employees in employee benefit plans
Edgar (US Regulatory)
27 Février 2025
KYMR (-14,45%)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Edgar (US Regulatory)
27 Février 2025
KYMR (-14,45%)

Form 8-K - Current report
Edgar (US Regulatory)
27 Février 2025
KYMR (-14,45%)

Form 8-K - Current report
Edgar (US Regulatory)
14 Janvier 2025
KYMR (-14,45%)
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-10.07-26.244461819138.3738.928.376655233.09467696CS
4-12.42-30.500982318340.7241.8528.353250635.60940266CS
12-15.87-35.929363821644.1747.4228.351258139.24317092CS
26-20.56-42.079410560848.8653.2728.345481143.19095975CS
52-14.65-34.109429569342.9553.2728.352032440.49122272CS
156-11.3-28.535353535439.653.279.660927529.8730671CS
260-4.62-14.034021871232.9291.929.651237734.32398436CS

KYMR - Frequently Asked Questions (FAQ)

What is the current Kymera Therapeutics share price?
The current share price of Kymera Therapeutics is US$ 28,30
How many Kymera Therapeutics shares are in issue?
Kymera Therapeutics has 64 765 274 shares in issue
What is the market cap of Kymera Therapeutics?
The market capitalisation of Kymera Therapeutics is USD 1,96B
What is the 1 year trading range for Kymera Therapeutics share price?
Kymera Therapeutics has traded in the range of US$ 28,30 to US$ 53,27 during the past year
What is the PE ratio of Kymera Therapeutics?
The price to earnings ratio of Kymera Therapeutics is -13,33
What is the cash to sales ratio of Kymera Therapeutics?
The cash to sales ratio of Kymera Therapeutics is 24,93
What is the reporting currency for Kymera Therapeutics?
Kymera Therapeutics reports financial results in USD
What is the latest annual turnover for Kymera Therapeutics?
The latest annual turnover of Kymera Therapeutics is USD 78,59M
What is the latest annual profit for Kymera Therapeutics?
The latest annual profit of Kymera Therapeutics is USD -146,96M
What is the registered address of Kymera Therapeutics?
The registered address for Kymera Therapeutics is CORPORATION TRUST CENTER, 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Kymera Therapeutics website address?
The website address for Kymera Therapeutics is www.kymeratx.com
Which industry sector does Kymera Therapeutics operate in?
Kymera Therapeutics operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
STAKSTAK Inc
US$ 3,58
(130,97%)
106
PMAXPowell Max Ltd
US$ 0,637
(78,93%)
28,35M
BONBon Natural Life Ltd
US$ 1,44
(51,58%)
69
BSCSInvesco Bulletshares 2028 Corporate Bond ETF
US$ 29,99
(47,66%)
1
CDXSCodexis Inc
US$ 5,69
(44,78%)
68
NVNINVNI Group Ltd
US$ 0,809
(-59,55%)
454,05k
SPGCSacks Parente Golf Inc
US$ 0,2107
(-48,10%)
8,41M
DCGODocGo Inc
US$ 2,89
(-26,28%)
43,65k
MBIOMustang Bio Inc
US$ 2,08
(-24,09%)
10,66k
DLODLocal Ltd
US$ 10,69
(-22,25%)
13,95k
VRPXVirpax Pharmaceuticals Inc
US$ 0,2802
(23,33%)
30,55M
PMAXPowell Max Ltd
US$ 0,637
(78,93%)
28,35M
ADTXAditxt Inc
US$ 0,0729
(5,19%)
13,1M
ARBBARB IOT Group Ltd
US$ 0,647
(34,79%)
11,03M
TRNRInteractive Strength Inc
US$ 1,92
(25,49%)
10,97M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

NASDAQ
KYMR
Kymera Therapeutics
AQSE
BEG.GB
Begbies Traynor
BIT
UB1364
UniCredit Bank
BIT
P1R1T0
BNP Paribas Issuance
BIT
UC525Q
Unicredit Bank
BIT
P1PMG1
BNP Paribas Issuance
BIT
P19KC8
BNP Paribas Issuance
BIT
S28234
Societe Generale Effekten
BIT
UV8CT8
UniCredit Bank
BIT
F34705
Vontobel Financial Produ...
BIT
I10433
IT0005615775 20250602 42
BIT
I09518
Intesa Sanpaolo
BIT
UC4CT9
Unicredit Bank
TG
0SZ
Ready Capital
TG
ZS3
Finecobank
BIT
UB4Q5F
Unicredit Bank
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés

Supprimer les publicités

Inscrivez-vous pour une expérience sans publicité

Aucune publicité

Essayez maintenant

Conserver les annonces